9 results on '"Nolla, J.M."'
Search Results
2. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
- Author
-
Rabiee R.H.S., Kan H., Karch A., Karimkhani C., Kaul A., Keiyoro P.N., Lyons R.A., Keren A., Khader Y.S., Khan E.A., Khang Y.H., Won S., Khera S., Tavakkoli M., Khoja T.A.M., Khubchandani J., Kim C., Kim D., Kim Y.J., Skogen J.C., Savic M., Kokubo Y., Kolte D., McGarvey S.T., Kosen S., Koul P.A., Koyanagi A., Kravchenko M., Varakin Y.Y., Kuate Defo B., Kucuk Bicer B., Kudom A.A., Polinder S., Kuipers E.J., Lallukka T., Shiri R., Meretoja T.J., Lam H., Lam J.O., Nachega J.B., Tran B.X., Langan S.M., McKee M., Lavados P.M., Leasher J.L., Leung R., Levi M., Li Y., Liang J., Liu Y., Phillips M.R., Lloyd B.K., Logroscino G., Looker K.J., Lunevicius R., Mackay M.T., Magdy Abd El Razek M., Mahdavi M., Marcenes W., Meaney P.A., Margolis D.J., Martinez-Raga J., McMahon B.J., Mehari A., Tedla B.A., Memiah P., Memish Z.A., Mendoza W., Mhimbira F.A., Miller T.R., Mills E.J., Mohammadi A., Monasta L., Montico M., Ronfani L., Morawska L., Norman R.E., Werdecker A., Mueller U.O., Westerman R., Paternina Caicedo A.J., Murdoch M.E., Seedat S., Wiysonge C.S., Nagel G., Rothenbacher D., Naheed A., Naldi L., Nangia V., Ngalesoni F.N., Nguyen Q.L., Nkamedjie Pete P.M., Nolla J.M., Nunes B.P., Ogbo F.A., Oh I., Ohkubo T., Olivares P.R., Olusanya B.O., Olusanya J.O., Ortiz A., Ota E., Park E., Passos V.M.D.A., Patten S.B., Tonelli M., Pereira D.M., Perez-Padilla R., Pesudovs K., Pillay J.D., Plass D., Platts-Mills J.A., Pond C.D., Prasad N.M., Qorbani M., Radfar A., Rafay A., Rahman M., Rahman S.U., Rai R.K., Rajsic S., Refaat A.H., Ribeiro A.L., Rojas-Rueda D., Roy A., Sagar R., Satpathy M., Tandon N., Sahathevan R., Sanabria J.R., Sanchez-Nino M.D., Sarmiento-Suarez R., Sartorius B., Sawhney M., Schaub M.P., Schneider I.J.C., Silva D.A.S., Schottker B., Schwebel D.C., Singh J.A., Shaheen A., Shaikh M.A., Sharma R., Sharma U., Shin M., Yoon S., Sigfusdottir I.D., Silveira D.G.A., Singh O.P., Singh P.K., Soreide K., Sliwa K., Stein D.J., Soriano J.B., Sposato L.A., Sreeramareddy C.T., Stathopoulou V., Stovner L.J., Steinke S., Stroumpoulis K., Sunguya B.F., Swaminathan S., Sykes B.L., Tabares-Seisdedos R., Takala J.S., Tanne D., Terkawi A.S., Tuzcu E.M., Thomson A.J., Thurston G.D., Tobe-Gai R., Topor-Madry R., Topouzis F., Truelsen T., Tsala Dimbuene Z., Tsilimbaris M., Tyrovolas S., Ukwaja K.N., Uneke C.J., Uthman O.A., van Gool C.H., Vasankari T., Venketasubramanian N., Violante F.S., Vladimirov S.K., Vlassov V.V., Waller S.G., Weichenthal S., White R.A., Williams H.C., Wubshet M., Xavier D., Xu G., Yan L.L., Yano Y., Yip P., Yonemoto N., Younis M.Z., Yu C., Zaidi Z., Zaki M.E., Zeeb H., Zuhlke L.J., Vos T., Allen C., Arora M., Barber R.M., Brown A., Carter A., Casey D.C., Charlson F.J., Chen A.Z., Coggeshall M., Cornaby L., Dandona L., Dicker D.J., Dilegge T., Erskine H.E., Ferrari A.J., Fitzmaurice C., Fleming T., Forouzanfar M.H., Fullman N., Goldberg E.M., Graetz N., Haagsma J.A., Hay S.I., Johnson C.O., Kassebaum N.J., Kawashima T., Kemmer L., Khalil I.A., Kyu H.H., Leung J., Lim S.S., Lopez A.D., Marczak L., Mokdad A.H., Naghavi M., Nguyen G., Nsoesie E., Olsen H., Pigott D.M., Pinho C., Rankin Z., Reinig N., Sandar L., Smith A., Stanaway J., Steiner C., Teeple S., Thomas B.A., Troeger C., Wagner J.A., Wang H., Wanga V., Whiteford H.A., Zoeckler L., Alexander L.T., Anderson G.M., Bell B., Bienhoff K., Biryukov S., Blore J., Brown J., Coates M.M., Daoud F., Estep K., Foreman K., Fox J., Friedman J., Frostad J., Godwin W.W., Hancock J., Huynh C., Iannarone M., Kim P., Kutz M., Masiye F., Millear A., Mirarefin M., Mooney M.D., Moradi-Lakeh M., Mullany E., Mumford J.E., Ng M., Rao P., Reitsma M.B., Reynolds A., Roth G.A., Shackelford K.A., Sivonda A., Sligar A., Sorensen R.J.D., Sur P., Vollset S.E., Woodbrook R., Zhou M., Murray C.J.L., Ellenbogen R.G., Kotsakis G.A., Mock C.N., Anderson B.O., Futran N.D., Jensen P.N., Watkins D.A., Bhutta Z.A., Nisar M.I., Akseer N., Abajobir A.A., Knibbs L.D., Lalloo R., Scott J.G., Alam N.K.M., Gouda H.N., Guo Y., McGrath J.J., Jeemon P., Dandona R., Kumar G.A., Gething P.W., Bisanzio D., Deribew A., Ali R., Bennett D.A., Rahimi K., Kinfu Y., Duan L., Liu S., Jin Y., Wang L., Ye P., Liang X., Azzopardi P., Gibney K.B., Meretoja A., Alam K., Borschmann R., Colquhoun S.M., Patton G.C., Weintraub R.G., Szoeke C.E.I., Ademi Z., Taylor H.R., Lozano R., Campos-Nonato I.R., Campuzano J.C., Gomez-Dantes H., Heredia-Pi I.B., Mejia-Rodriguez F., Montanez Hernandez J.C., Rios Blancas M.J., Servan-Mori E.E., Mensah G.A., Salomon J.A., Thorne-Lyman A.L., Ajala O.N., Barnighausen T., Ding E.L., Farvid M.S., Wagner G.R., Osman M., Shrime M.G., Fitchett J.R.A., Abate K.H., Gebrehiwot T.T., Gebremedhin A.T., Abbafati C., Abbas K.M., Abd-Allah F., Abraham B., Abubakar I., Banerjee A., Benzian H., Abu-Raddad L.J., Abu-Rmeileh N.M., Ackerman I.N., Buchbinder R., Gabbe B., Thrift A.G., Adebiyi A.O., Akinyemi R.O., Adou A.K., Afanvi K.A., Agardh E.E., Badawi A., Popova S., Agarwal A., Ahmad Kiadaliri A., Norrving B., Ahmadieh H., Yaseri M., Jahanmehr N., Al-Aly Z., Driscoll T.R., Kemp A.H., Leigh J., Mekonnen A.B., Aldhahri S.F., Altirkawi K.A., Alegretti M.A., Alemu Z.A., Alhabib S., Alkerwi A., Alla F., Guillemin F., Allebeck P., Carrero J.J., Fereshtehnejad S.M., Weiderpass E., Havmoeller R., Al-Raddadi R., Alsharif U., Alvis-Guzman N., Amare A.T., Melaku Y.A., Ciobanu L.G., Amberbir A., Amini H., Karema C.K., Ammar W., Harb H.L., Amrock S.M., Andersen H.H., Antonio C.A.T., Aregay A.F., Betsu B.D., Hailu G.B., Yebyo H.G., Arnlov J., Larsson A., Artaman A., Asayesh H., Assadi R., Atique S., Avokpaho E.F.G.A., Awasthi A., Ayala Quintanilla B.P., Bacha U., Balakrishnan K., Barac A., Barker-Collo S.L., Mohammed S., Barregard L., Petzold M., Barrero L.H., Basu A., Bazargan-Hejazi S., Beghi E., Sheth K.N., Bell M.L., Huang J.J., Santos I.S., Bensenor I.M., Lotufo P.A., Berhane A., Wolfe C.D., Bernabe E., Hay R.J., Roba H.S., Beyene A.S., Bhala N., Piel F.B., Steiner T.J., Bhatt S., Greaves F., Majeed A., Soljak M., Biadgilign S., Bikbov B., Bjertness E., Htet A.S., Boufous S., Degenhardt L., Resnikoff S., Calabria B., Mitchell P.B., Brainin M., Brazinova A., Majdan M., Lo W.D., Shen J., Breitborde N.J.K., Buckle G.C., Butt Z.A., Lal A., Carabin H., Cardenas R., Carpenter D.O., Castaneda-Orjuela C.A., Castillo Rivas J., Catala-Lopez F., Chang J., Chiang P.P., Chibueze C.E., Chisumpa V.H., Choi J.J., Chowdhury R., Christensen H., Christopher D.J., Cirillo M., Cooper C., Cortinovis Biotech M.D., Giussani Biol G., Perico D.N., Remuzzi G., Crump J.A., Derrett S., Poulton R.G., Damtew S.A., Deribe K., Hailu A.D., Giref A.Z., Haile D., Jibat T., Taye B., Dargan P.I., das Neves J., Massano J., Santos J.V., Davey G., Davis A.C., Newton J.N., Steel N., De Leo D., Del Gobbo L.C., Dellavalle R.P., Des Jarlais D.C., Dharmaratne S.D., Dhillon P.K., Ganguly P., Zodpey S., Diaz-Torne C., Dubey M., Rahman M.H.U., Ram U., Singh A., Verma R.K., Yadav A.K., Duncan B.B., Kieling C., Schmidt M.I., Ebrahimi H., Pishgar F., Farzadfar F., Kasaeian A., Parsaeian M., Heydarpour P., Malekzadeh R., Roshandel G., Sepanlou S.G., Rahimi-Movaghar V., Elyazar I., Endres M., Endries A.Y., Ermakov S.P., Eshrati B., Farid T.A., Khan A.R., Farinha C.S.E.S., Faro A., Feigin V.L., Te Ao B.J., Kwan G.F., Felson D.T., Fernandes J.G., Fernandes J.C., Fischer F., Shiue I., Fowkes F.G.R., Franklin R.C., Furst T., Iyer V.J., Gankpe F.G., Gebre T., Geleijnse J.M., Gessner B.D., Ginawi I.A., Giroud M., Gishu M.D., Tura A.K., Glaser E., Halasa Y.A., Shepard D.S., Undurraga E.A., Gona P., Goodridge A., Gopalani S.V., Gotay C.C., Kissoon N., Kopec J.A., Pourmalek F., Goto A., Inoue M., Grainger R., Gupta R., Gupta V., Gutierrez R.A., Knudsen A.K., Norheim O.F., Hamadeh R.R., Hamidi S., Hammami M., Handal A.J., Hankey G.J., Hao Y., Harikrishnan S., Haro J.M., Hoek H.W., Skirbekk V., Horino M., Horita N., Hosgood H.D., Hoy D.G., Huang H., Iburg K.M., Innos K., Kawakami N., Shibuya K., Jacobsen K.H., Jakovljevic M.B., Javanbakht M., Jayaraman S.P., Jayatilleke A.U., Jee S.H., Prabhakaran D., Jiang Y., Jimenez-Corona A., Jonas J.B., Kabir Z., Kalkonde Y., Kamal R., Kesavachandran C.N., Rabiee R.H.S., Kan H., Karch A., Karimkhani C., Kaul A., Keiyoro P.N., Lyons R.A., Keren A., Khader Y.S., Khan E.A., Khang Y.H., Won S., Khera S., Tavakkoli M., Khoja T.A.M., Khubchandani J., Kim C., Kim D., Kim Y.J., Skogen J.C., Savic M., Kokubo Y., Kolte D., McGarvey S.T., Kosen S., Koul P.A., Koyanagi A., Kravchenko M., Varakin Y.Y., Kuate Defo B., Kucuk Bicer B., Kudom A.A., Polinder S., Kuipers E.J., Lallukka T., Shiri R., Meretoja T.J., Lam H., Lam J.O., Nachega J.B., Tran B.X., Langan S.M., McKee M., Lavados P.M., Leasher J.L., Leung R., Levi M., Li Y., Liang J., Liu Y., Phillips M.R., Lloyd B.K., Logroscino G., Looker K.J., Lunevicius R., Mackay M.T., Magdy Abd El Razek M., Mahdavi M., Marcenes W., Meaney P.A., Margolis D.J., Martinez-Raga J., McMahon B.J., Mehari A., Tedla B.A., Memiah P., Memish Z.A., Mendoza W., Mhimbira F.A., Miller T.R., Mills E.J., Mohammadi A., Monasta L., Montico M., Ronfani L., Morawska L., Norman R.E., Werdecker A., Mueller U.O., Westerman R., Paternina Caicedo A.J., Murdoch M.E., Seedat S., Wiysonge C.S., Nagel G., Rothenbacher D., Naheed A., Naldi L., Nangia V., Ngalesoni F.N., Nguyen Q.L., Nkamedjie Pete P.M., Nolla J.M., Nunes B.P., Ogbo F.A., Oh I., Ohkubo T., Olivares P.R., Olusanya B.O., Olusanya J.O., Ortiz A., Ota E., Park E., Passos V.M.D.A., Patten S.B., Tonelli M., Pereira D.M., Perez-Padilla R., Pesudovs K., Pillay J.D., Plass D., Platts-Mills J.A., Pond C.D., Prasad N.M., Qorbani M., Radfar A., Rafay A., Rahman M., Rahman S.U., Rai R.K., Rajsic S., Refaat A.H., Ribeiro A.L., Rojas-Rueda D., Roy A., Sagar R., Satpathy M., Tandon N., Sahathevan R., Sanabria J.R., Sanchez-Nino M.D., Sarmiento-Suarez R., Sartorius B., Sawhney M., Schaub M.P., Schneider I.J.C., Silva D.A.S., Schottker B., Schwebel D.C., Singh J.A., Shaheen A., Shaikh M.A., Sharma R., Sharma U., Shin M., Yoon S., Sigfusdottir I.D., Silveira D.G.A., Singh O.P., Singh P.K., Soreide K., Sliwa K., Stein D.J., Soriano J.B., Sposato L.A., Sreeramareddy C.T., Stathopoulou V., Stovner L.J., Steinke S., Stroumpoulis K., Sunguya B.F., Swaminathan S., Sykes B.L., Tabares-Seisdedos R., Takala J.S., Tanne D., Terkawi A.S., Tuzcu E.M., Thomson A.J., Thurston G.D., Tobe-Gai R., Topor-Madry R., Topouzis F., Truelsen T., Tsala Dimbuene Z., Tsilimbaris M., Tyrovolas S., Ukwaja K.N., Uneke C.J., Uthman O.A., van Gool C.H., Vasankari T., Venketasubramanian N., Violante F.S., Vladimirov S.K., Vlassov V.V., Waller S.G., Weichenthal S., White R.A., Williams H.C., Wubshet M., Xavier D., Xu G., Yan L.L., Yano Y., Yip P., Yonemoto N., Younis M.Z., Yu C., Zaidi Z., Zaki M.E., Zeeb H., Zuhlke L.J., Vos T., Allen C., Arora M., Barber R.M., Brown A., Carter A., Casey D.C., Charlson F.J., Chen A.Z., Coggeshall M., Cornaby L., Dandona L., Dicker D.J., Dilegge T., Erskine H.E., Ferrari A.J., Fitzmaurice C., Fleming T., Forouzanfar M.H., Fullman N., Goldberg E.M., Graetz N., Haagsma J.A., Hay S.I., Johnson C.O., Kassebaum N.J., Kawashima T., Kemmer L., Khalil I.A., Kyu H.H., Leung J., Lim S.S., Lopez A.D., Marczak L., Mokdad A.H., Naghavi M., Nguyen G., Nsoesie E., Olsen H., Pigott D.M., Pinho C., Rankin Z., Reinig N., Sandar L., Smith A., Stanaway J., Steiner C., Teeple S., Thomas B.A., Troeger C., Wagner J.A., Wang H., Wanga V., Whiteford H.A., Zoeckler L., Alexander L.T., Anderson G.M., Bell B., Bienhoff K., Biryukov S., Blore J., Brown J., Coates M.M., Daoud F., Estep K., Foreman K., Fox J., Friedman J., Frostad J., Godwin W.W., Hancock J., Huynh C., Iannarone M., Kim P., Kutz M., Masiye F., Millear A., Mirarefin M., Mooney M.D., Moradi-Lakeh M., Mullany E., Mumford J.E., Ng M., Rao P., Reitsma M.B., Reynolds A., Roth G.A., Shackelford K.A., Sivonda A., Sligar A., Sorensen R.J.D., Sur P., Vollset S.E., Woodbrook R., Zhou M., Murray C.J.L., Ellenbogen R.G., Kotsakis G.A., Mock C.N., Anderson B.O., Futran N.D., Jensen P.N., Watkins D.A., Bhutta Z.A., Nisar M.I., Akseer N., Abajobir A.A., Knibbs L.D., Lalloo R., Scott J.G., Alam N.K.M., Gouda H.N., Guo Y., McGrath J.J., Jeemon P., Dandona R., Kumar G.A., Gething P.W., Bisanzio D., Deribew A., Ali R., Bennett D.A., Rahimi K., Kinfu Y., Duan L., Liu S., Jin Y., Wang L., Ye P., Liang X., Azzopardi P., Gibney K.B., Meretoja A., Alam K., Borschmann R., Colquhoun S.M., Patton G.C., Weintraub R.G., Szoeke C.E.I., Ademi Z., Taylor H.R., Lozano R., Campos-Nonato I.R., Campuzano J.C., Gomez-Dantes H., Heredia-Pi I.B., Mejia-Rodriguez F., Montanez Hernandez J.C., Rios Blancas M.J., Servan-Mori E.E., Mensah G.A., Salomon J.A., Thorne-Lyman A.L., Ajala O.N., Barnighausen T., Ding E.L., Farvid M.S., Wagner G.R., Osman M., Shrime M.G., Fitchett J.R.A., Abate K.H., Gebrehiwot T.T., Gebremedhin A.T., Abbafati C., Abbas K.M., Abd-Allah F., Abraham B., Abubakar I., Banerjee A., Benzian H., Abu-Raddad L.J., Abu-Rmeileh N.M., Ackerman I.N., Buchbinder R., Gabbe B., Thrift A.G., Adebiyi A.O., Akinyemi R.O., Adou A.K., Afanvi K.A., Agardh E.E., Badawi A., Popova S., Agarwal A., Ahmad Kiadaliri A., Norrving B., Ahmadieh H., Yaseri M., Jahanmehr N., Al-Aly Z., Driscoll T.R., Kemp A.H., Leigh J., Mekonnen A.B., Aldhahri S.F., Altirkawi K.A., Alegretti M.A., Alemu Z.A., Alhabib S., Alkerwi A., Alla F., Guillemin F., Allebeck P., Carrero J.J., Fereshtehnejad S.M., Weiderpass E., Havmoeller R., Al-Raddadi R., Alsharif U., Alvis-Guzman N., Amare A.T., Melaku Y.A., Ciobanu L.G., Amberbir A., Amini H., Karema C.K., Ammar W., Harb H.L., Amrock S.M., Andersen H.H., Antonio C.A.T., Aregay A.F., Betsu B.D., Hailu G.B., Yebyo H.G., Arnlov J., Larsson A., Artaman A., Asayesh H., Assadi R., Atique S., Avokpaho E.F.G.A., Awasthi A., Ayala Quintanilla B.P., Bacha U., Balakrishnan K., Barac A., Barker-Collo S.L., Mohammed S., Barregard L., Petzold M., Barrero L.H., Basu A., Bazargan-Hejazi S., Beghi E., Sheth K.N., Bell M.L., Huang J.J., Santos I.S., Bensenor I.M., Lotufo P.A., Berhane A., Wolfe C.D., Bernabe E., Hay R.J., Roba H.S., Beyene A.S., Bhala N., Piel F.B., Steiner T.J., Bhatt S., Greaves F., Majeed A., Soljak M., Biadgilign S., Bikbov B., Bjertness E., Htet A.S., Boufous S., Degenhardt L., Resnikoff S., Calabria B., Mitchell P.B., Brainin M., Brazinova A., Majdan M., Lo W.D., Shen J., Breitborde N.J.K., Buckle G.C., Butt Z.A., Lal A., Carabin H., Cardenas R., Carpenter D.O., Castaneda-Orjuela C.A., Castillo Rivas J., Catala-Lopez F., Chang J., Chiang P.P., Chibueze C.E., Chisumpa V.H., Choi J.J., Chowdhury R., Christensen H., Christopher D.J., Cirillo M., Cooper C., Cortinovis Biotech M.D., Giussani Biol G., Perico D.N., Remuzzi G., Crump J.A., Derrett S., Poulton R.G., Damtew S.A., Deribe K., Hailu A.D., Giref A.Z., Haile D., Jibat T., Taye B., Dargan P.I., das Neves J., Massano J., Santos J.V., Davey G., Davis A.C., Newton J.N., Steel N., De Leo D., Del Gobbo L.C., Dellavalle R.P., Des Jarlais D.C., Dharmaratne S.D., Dhillon P.K., Ganguly P., Zodpey S., Diaz-Torne C., Dubey M., Rahman M.H.U., Ram U., Singh A., Verma R.K., Yadav A.K., Duncan B.B., Kieling C., Schmidt M.I., Ebrahimi H., Pishgar F., Farzadfar F., Kasaeian A., Parsaeian M., Heydarpour P., Malekzadeh R., Roshandel G., Sepanlou S.G., Rahimi-Movaghar V., Elyazar I., Endres M., Endries A.Y., Ermakov S.P., Eshrati B., Farid T.A., Khan A.R., Farinha C.S.E.S., Faro A., Feigin V.L., Te Ao B.J., Kwan G.F., Felson D.T., Fernandes J.G., Fernandes J.C., Fischer F., Shiue I., Fowkes F.G.R., Franklin R.C., Furst T., Iyer V.J., Gankpe F.G., Gebre T., Geleijnse J.M., Gessner B.D., Ginawi I.A., Giroud M., Gishu M.D., Tura A.K., Glaser E., Halasa Y.A., Shepard D.S., Undurraga E.A., Gona P., Goodridge A., Gopalani S.V., Gotay C.C., Kissoon N., Kopec J.A., Pourmalek F., Goto A., Inoue M., Grainger R., Gupta R., Gupta V., Gutierrez R.A., Knudsen A.K., Norheim O.F., Hamadeh R.R., Hamidi S., Hammami M., Handal A.J., Hankey G.J., Hao Y., Harikrishnan S., Haro J.M., Hoek H.W., Skirbekk V., Horino M., Horita N., Hosgood H.D., Hoy D.G., Huang H., Iburg K.M., Innos K., Kawakami N., Shibuya K., Jacobsen K.H., Jakovljevic M.B., Javanbakht M., Jayaraman S.P., Jayatilleke A.U., Jee S.H., Prabhakaran D., Jiang Y., Jimenez-Corona A., Jonas J.B., Kabir Z., Kalkonde Y., Kamal R., and Kesavachandran C.N.
- Abstract
Background Non-fatal outcomes of disease and injury increasingly detract from the ability of the world's population to live in full health, a trend largely attributable to an epidemiological transition in many countries from causes affecting children, to non-communicable diseases (NCDs) more common in adults. For the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015), we estimated the incidence, prevalence, and years lived with disability for diseases and injuries at the global, regional, and national scale over the period of 1990 to 2015. Methods We estimated incidence and prevalence by age, sex, cause, year, and geography with a wide range of updated and standardised analytical procedures. Improvements from GBD 2013 included the addition of new data sources, updates to literature reviews for 85 causes, and the identification and inclusion of additional studies published up to November, 2015, to expand the database used for estimation of non-fatal outcomes to 60 900 unique data sources. Prevalence and incidence by cause and sequelae were determined with DisMod-MR 2.1, an improved version of the DisMod-MR Bayesian meta-regression tool first developed for GBD 2010 and GBD 2013. For some causes, we used alternative modelling strategies where the complexity of the disease was not suited to DisMod-MR 2.1 or where incidence and prevalence needed to be determined from other data. For GBD 2015 we created a summary indicator that combines measures of income per capita, educational attainment, and fertility (the Socio-demographic Index [SDI]) and used it to compare observed patterns of health loss to the expected pattern for countries or locations with similar SDI scores. Findings We generated 9.3 billion estimates from the various combinations of prevalence, incidence, and YLDs for causes, sequelae, and impairments by age, sex, geography, and year. In 2015, two causes had acute incidences in excess of 1 billion: upper respiratory infections (17.2 bi
- Published
- 2016
3. Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis.
- Author
-
Narváez, J., Estrada, P., Vidal-Montal, P., Sánchez-Rodríguez, I., Sabaté-Llobera, A., Nolla, J.M., and Cortés-Romera, M.
- Abstract
To evaluate the impact of prior glucocorticoid (GC) treatment on the diagnostic accuracy of
18 F-FDG PET-CT in giant cell arteritis (GCA). Retrospective study of a consecutive cohort of 85 patients with proven GCA who received high-dose GC before PET-CT. Thirty-nine patients previously treated with methylprednisolone (MP) boluses, of whom 37% were PET-CT (uptakes grade 3 or 2) positive. The positivity rate was 80% with MP doses of 125 mg, 33% with 250 or 500 mg, and 0% with doses of 1 g. If we also classify as positive those cases with a grade 1 uptake (with a circumferencial uptake and smooth linear or long segmental pattern, possibly indicative of "apparently inactive" vasculitis), the positivity rate increases to 62% (100%, 50–60%, and 33% for the different MP doses, respectively). In patients with new-onset GCA treated with high-dose oral GC, PET-CT positivity was 54.5% in patients treated for less than two weeks, 38.5% in those treated for 2 to 4 weeks, and 25% in those treated for 4 to 6 weeks (increasing to 91%, 77%, and 50%, respectively, if we include cases with grade 1 uptake and these characteristics). In patients with relapsing/refractory GCA, or who developed GCA having a prior history of PMR, PET-CT positivity reached 54% despite long-term treatment with low-to-moderate doses of GC (68% including cases with a grade 1 uptake). A late18 F-FDG PET-CT (beyond the first 10 days of treatment) can also be informative in a considerable percentage of cases. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
4. P1465 Long-term clinical and radiological (MRI) outcome of abscess-associated spontaneous pyogenic vertebral osteomyelitis under conservative management
- Author
-
Euba, G., Narvaez, J.A., Nolla, J.M., Murillo, O., Narvaez, J., Gomez, C., and Ariza, J.
- Published
- 2007
- Full Text
- View/download PDF
5. Effectiveness and safety of rituximab for the treatment of refractory systemic sclerosis associated calcinosis: A case series and systematic review of the literature.
- Author
-
Narváez, J., Pirola, J.P., LLuch, J., Juarez, P., Nolla, J.M., and Valenzuela, A.
- Subjects
- *
CALCINOSIS , *SYSTEMIC scleroderma , *RESPIRATORY infections , *META-analysis - Abstract
Abstract Objective To analyze the effectiveness and safety of rituximab (RTX) for the treatment of refractory systemic sclerosis (SSc)–associated calcinosis. Methods We undertook an observational study of patients with this complication treated with 1 or more cycles of RTX (1 g × 2 weeks) and evaluated for at least 12 months after RTX treatment in a single center. The primary outcome measures of the study were the improvement of calcinosis symptoms (pain, signs of local inflammation, and new episodes of skin ulceration) and the radiologic evolution of the calcification(s). Results We treated 8 patients with refractory SSc-related calcinosis with RTX (off-label use). The main indications for RTX were complicated calcinosis unresponsive to previous therapies with concomitant arthritis in 2 patients and refractory arthritis or interstitial lung fibrosing disease in the remaining 6 patients. The mean number of RTX cycles administered was 3.12 ± 2.1 (range, 1-7), the median duration of RTX treatment was 9 months (interquartile range [IQR], 7.5-36 months), and the median follow-up after the first infusion of RTX dose was 19 months (IQR, http://catsalut.gencat.cat/web/.content/minisite/catsalut/proveidors%5fprofessionals/medicaments%5ffarmacia/phf%5fmhda/informes%5fcamse/esclerosi%5fsistemica/Dictamen-CAMS%5f-ES%5f-web.pdf (n.d.) 5-45 months). Four patients (50%) had a significant improvement in clinical symptoms (sustained improvement in the visual analog scale for pain of at least 50% and no new episodes of local inflammation or skin ulceration). Two of these patients (25%) also had a complete resolution or significant reduction in the size of the calcification(s) on X-ray, according with the radiographical scoring system for calcinosis developed by the Scleroderma Clinical Trials Consortium. In the remaining 4 patients (50%), RTX did not provide any significant clinical or radiologic benefit for calcinosis. The frequency of adverse effects was low, occurring in only 1 patient (12.5%), who developed upper respiratory tract infections not requiring hospitalization. Conclusion Our preliminary data suggest that RTX may be helpful as a rescue therapy in selected cases of severe and refractory SSc-related calcinosis. Highlights • To date, there is no definitely effective treatment for systemic sclerosis (SSc)-associated calcinosis. • New therapeutic options with greater efficacy are clearly needed to properly manage these patients. • RTX may be helpful as a rescue therapy in selected cases of severe and refractory SSc-related calcinosis. • Rituximab has reasonable safety profile in patients with systemic sclerosis [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
6. Physicians' and Patients' Preferences Over the Attributes of Biological Agents Used In the Treatment of Rheumatic Diseases In Spain: A Conjoint Analysis.
- Author
-
Martin, E., Rodriguez, M., Ibero, I., Raya, E., Nolla, J.M., Nocea, G., Aragon, B., Lizán, L., and Paz, S.
- Subjects
- *
RHEUMATISM treatment , *PHYSICIAN-patient relations , *BIOLOGICALS , *CONJOINT analysis , *PUBLIC health - Published
- 2014
- Full Text
- View/download PDF
7. Preferences of Spanish Patients Over the Attributes of Biological Agents for the Treatment of Rheumatic Diseases Depending On the Administration Route.
- Author
-
Rodriguez, M., Ibero, I., Martin, E., Nolla, J.M., Raya, E., Aragon, B., Nocea, G., Lizán, L., and Aceituno, S.
- Subjects
- *
RHEUMATISM treatment , *DRUG therapy , *DRUG administration , *PATIENT psychology , *INDIVIDUALS' preferences , *SCIENTIFIC observation , *ADVERSE health care events - Published
- 2014
- Full Text
- View/download PDF
8. Changes in serum PINP during teriparatide therapy correlate with improvements in vertebral strength as assessed by finite element modeling in men with glucocorticoid-induced osteoporosis
- Author
-
⁎, P., Marin, F., Hawkins, F., Möricke, R., Ringe, J.D., Glüer, C.C., Papaioannu, N., Minisola, S., Martínez, G., Nolla, J.M., Niedhart, C., Guañabens, N., Nuti, R., Martín-Mola, E., Thomasius, F., Kapetanos, G., Peña, J., Graeff, C., Petto, H., and Gentzel, A.
- Published
- 2012
- Full Text
- View/download PDF
9. Teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPS trial
- Author
-
⁎, C.C., Marin, F., Ringe, J.D., Hawkins, F., Möricke, R., Papaioannu, N., Farahmand, P., Minisola, S., Martínez, G., Nolla, J.M., Niedhart, C., Guañabens, N., Nuti, R., Martín-Mola, E., Thomasius, F., Kapetanos, G., Peña, J., Graeff, C., Petto, H., and Sanz, B.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.